McKesson

News

Reuters - 3 days ago

Baltimore to take drug distributors to trial over opioids

UPDATE 1-Baltimore to take drug distributors to trial over opioids Adds comment from Cencora in paragraph 4 By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.

Reuters - 3 days ago

Baltimore to take drug distributors to trial over opioids

CORRECTED-Baltimore to take drug distributors to trial over opioids Corrects headline and lead, adds paragraphs 4-5 to state that J&J settled before trial By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.

Reuters - 1 week ago

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

UPDATE 1-Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial Adds comment from J&J in paragraph 6 By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.

Reuters - 1 week ago

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.

Reuters - 1 week ago

U.S. STOCKS JPMorgan, automakers, energy firms

BUZZ-U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday ahead of key inflation data later this week that could provide clarity on the extent of the Federal Reserve's expected interest rate cut, while a fall in the shares of big banks weighed on the markets.

Reuters - 1 week ago

U.S. STOCKS Arrowhead Pharma, Boeing, Centessa Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq rose on Tuesday as most megacap stocks gained, with focus now moving to key inflation data later this week that could provide more clarity on the extent of the Federal Reserve's expected interest rate cut on Sept.

Reuters - 1 week ago

Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal

BUZZ-Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal ** Brokerage Jefferies cuts PT on drug distributor McKesson MCK.N to $607 from $630, while raising PT on peer Cardinal Health CAH.N to $110 from $105 ** Says despite MCK forecasting Q2 below estimates, co's reiteration of full-year forecast gives "some level of confidence" *

Reuters - 1 week ago

Column: Opioid plaintiffs' committee urges US appeals court to toss fee bid by shut-out law firms

Column: Opioid plaintiffs' committee urges US appeals court to toss fee bid by shut-out law firms The opinions expressed here are those of the author, a columnist for Reuters. By Alison Frankel Sept 9 (Reuters) - When it comes to calling dibs on $2.1 billion set aside for lawyers who contributed to settlements with nine major opioids defendants, the plaintiffs' lawyers in charge of the sweeping nationwide case are not kidding around.

Reuters - 2 weeks ago

U.S. Broadcom, Costco Wholesale, Saia

U.S. RESEARCH ROUNDUP-Broadcom, Costco Wholesale, Saia Sept 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Broadcom, Costco Wholesale and Saia on Friday. HIGHLIGHTS * Broadcom Inc AVGO.O : JP Morgan raises target price to $210 from $200 * Costco Wholesale Corp COST.O : Oppenheimer raises target price to $955 from $925 * Globant SA GLOB.N : JP Morgan raises target price to $237 from $226 * Saia Inc SAIA.O : JP Morg

Reuters - 2 weeks ago

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Dollar Tree Inc DLTR.OQ +6.8% Marketaxess Holdings Inc MKTX.OQ +6.5% Tesla Inc TSLA.OQ +4.4% Hormel Foods Corp HRL.N +3.0% Comcast Corp CMCSA.OQ +2.7% Bottom Performers Percent Change Mckesson Corp MCK.N -11.1% Zimmer Biomet Holdings I

Reuters - 2 weeks ago

U.S. STOCKS MarketAxess, Perpetua Resources, Sotera Health

BUZZ-U.S. STOCKS ON THE MOVE-MarketAxess, Perpetua Resources, Sotera Health Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's three main indexes slipped in choppy trading on Thursday as a short-lived boost from a services activity survey fizzled out ahead of an upcoming employment report.

Reuters - 2 weeks ago

Drug distributor McKesson forecasts Q2 profit below estimates

UPDATE 1-Drug distributor McKesson forecasts Q2 profit below estimates Adds shares in paragraph 1, details and background throughout Sept 5 (Reuters) - Drug distributor McKesson MCK.N on Thursday forecast second-quarter profit below Wall Street estimates, sending its shares down 9%. The company said in a filing it expects adjusted profit for the second quarter to be between $6.70 and $7 per share, below analysts' average estimate of $7.39, according to LSEG data.

Reuters - 2 weeks ago

McKesson falls after forecasting Q2 profit below estimates

BUZZ-McKesson falls after forecasting Q2 profit below estimates ** Shares of drug distributor McKesson Corp MCK.N fall 9% to $519.89 ** Co sees Q2 adjusted profit per share in the range of $6.70 to $7.00 vs estimates of $7.39 -LSEG ** Reaffirms fiscal 2025 adjusted per-share profit to be between $31.75 and $32.55 ** Stock down ~13% YTD Reporting by

Reuters - 2 weeks ago

Drug distributor McKesson forecasts Q2 profit below estimates

Drug distributor McKesson forecasts Q2 profit below estimates Sept 5 (Reuters) - Drug distributor McKesson MCK.N on Thursday forecast second-quarter profit below Wall Street estimates. The company expects adjusted profit for the second quarter to be between $6.70 and $7 per share, compared with analysts' average estimate of $7.39, according to LSEG data.

Reuters - 2 weeks ago

U.S. STOCKS Modular Medical, Beazer Homes, oil firms

BUZZ-U.S. STOCKS ON THE MOVE-Modular Medical, Beazer Homes, oil firms Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 inched up on Thursday after a services activity survey allayed some fears of a slowdown in economic activity, while focus continues to be on the Federal Reserve's interest rate cut that is expected later this month.

Reuters - 2 weeks ago

Mckesson Corp Reaffirms Fiscal 2025 Adjusted EPS Guidance

BRIEF-Mckesson Corp Reaffirms Fiscal 2025 Adjusted EPS Guidance Sept 5 (Reuters) - Mckesson Corp MCK.N : AFFIRMED FISCAL 2025 ADJUSTED EPS GUIDANCE IN RANGE OF $31.75 TO $32.55 : SEES Q2 FISCAL 2025 ADJUSTED EARNINGS PER DILUTED SHARE TO BE IN RANGE OF $6.70 TO $7.00 FY2025 EARNINGS PER SHARE VIEW $32.21 -- LSEG IBES DATA Q2 EARNINGS PER SHARE VIEW

Reuters - 2 weeks ago

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Marketaxess Holdings Inc MKTX.OQ +5.3% United Airlines Holdings Inc UAL.OQ +3.6% Insulet Corp PODD.OQ +3.0% Tesla Inc TSLA.OQ +2.9% Merck & Co Inc MRK.N +2.9% Bottom Performers Percent Change Mckesson Corp MCK.N -8.7% Zimmer Biomet Hol

Reuters - 2 weeks ago

McKesson Announces Sale Of Rexall And Well.ca Businesses To Birch Hill Equity Partners

BRIEF-McKesson Announces Sale Of Rexall And Well.ca Businesses To Birch Hill Equity Partners Sept 5 (Reuters) - Mckesson Corp MCK.N : MCKESSON CORPORATION ANNOUNCES SALE OF REXALL AND WELL.CA BUSINESSES TO BIRCH HILL EQUITY PARTNERS Source text for Eikon: ID:nBw2RylTpa Further company coverage: MCK.N

Reuters - 2 weeks ago

US pharmacy chain Rite Aid to operate as a private company as it emerges from bankruptcy

UPDATE 3-US pharmacy chain Rite Aid to operate as a private company as it emerges from bankruptcy Adds detail about store closures in paragraphs 10-11 Sept 3 (Reuters) - Rite Aid will operate as a private company after it successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy, the U.S. drugstore chain said on Tuesday.

Reuters - 3 weeks ago

Drug distributors strike $300 mln opioid settlement with US health plans

UPDATE 1-Drug distributors strike $300 mln opioid settlement with US health plans Adds further details on settlement in paragraphs 3-7 By Nate Raymond Aug 30 (Reuters) - The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they helped fuel the deadly U.S. opioid epidemic, according to court papers filed on Friday.

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

McKesson

News

Conditions

Popular Assets

XM Live Chat